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of macrophages, lymphocytes, and dendritic cells to the site of 
infection resulting in the formation of a granuloma, a signature 
histopathological feature of TB (Ulrichs and Kaufmann, 2006).
The major function of granulomas in TB disease is the contain-
ment of Mtb to a localized area, to prevent the spread of disease 
to other healthy regions of tissue. TB disease occurs upon Mtb 
growth and disruption of the granuloma structure, leading to cavi-
tation and dissemination. The structure, function, and evolution 
of granulomas have been studied using various animal models 
(Bouley et al., 2001; Saunders et al., 2002; Via et al., 2008), within 
lungs of tuberculous humans (Im et al., 1993; Poey et al., 1997; 
Long et al., 1998), explant tissue (Kaplan et al., 2003; Ulrichs et al., 
2004; Tsai et al., 2006; Ulrichs and Kaufmann, 2006), and in vitro 
cell cultures (Puissegur et al., 2004). These studies have identi-
fied that Mtb infected monocytes differentiate into macrophages, 
epithelioid cells, and several types of multinucleated giant cells 
(MNGCs). Interestingly, some of these studies have implicated 
MNGCs as enhancing bacterial containment and clearance within 
the granuloma. MNGCs were thought to express increased lytic 
enzyme activity.
Although the presence of MNGCs was described very early 
within tuberculosis lesions, their precise formation and contri-
bution is only being analyzed recently. Cultured monocytes and 
macrophages have been induced to differentiate into MNGCs 
by exposure to various stimulants, such as cytokines (Weinberg 
et al., 1984; McInnes and Rennick, 1988; Enelow et al., 1992; 
IntroductIon
Tuberculosis (TB), a disease that afflicts mankind, causes 1.3 million 
deaths per year (WHO, 2006). The etiologic agent, Mycobacterium 
tuberculosis (Mtb) is unique among bacterial pathogens in being 
able to survive in vivo for years before reactivation to cause disease. 
The clinical manifestations of TB represent a complex interaction 
between the pathogen and the human host immune response. 
Although Mtb can parasitize, survive and grow within macro-
phages only a minority of people exposed to infection progress to 
disease. This indicates that innate mechanisms may contain disease 
in exposed populations. It is widely believed that protection against 
the human disease requires the T-helper 1-type (Th1) immune 
responses (Toossi, 2000).
The host mediated Th1 immune response results in granuloma 
formation that is sufficient to contain the infection and prevent 
active disease in most healthy individuals. However, granulomas 
are unable to completely eradicate the infection (Saunders et al., 
1999). Pulmonary TB infection is primarily acquired through inha-
lation of aerosol droplets containing Mtb. Following Mtb infection 
of alveolar macrophages, an intense local inflammatory response 
involving a series of innate immune and Th1 dominant adaptive 
pathways are triggered. These responses lead to the recruitment 
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Mycobacterium tuberculosis (Mtb) replicates within the human macrophages and we investigated 
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viability of intracellular Mtb. A combination of these vitamins (RAVD) enhanced the levels of 
DC-SIGN and mannose receptors on THP-1 macrophages that increased mycobacterial uptake 
but inhibited the subsequent intracellular growth of Mtb by inducing reactive oxygen species 
and autophagy. RAVD also enhanced antigen presenting and chemotactic receptors on THPs 
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(10 ng/mL = 16 nM; all from Sigma Aldrich, St Louis, MO, USA) 
for 3 days. RAVD concentrations were selected based on the physi-
ological levels that occur in the fluids of humans (Hollis, 2005; 
Moan et al., 2009). It is noted here that the cholecalciferol version 
of VD was used in this study. VD is predominantly metabolized 
to 1,25-dihydroxyvitamin D
3
 in the liver and kidneys. However, 
during infection, macrophages and dendritic cells have been shown 
to metabolize cholecalciferol for use in their antimicrobial proc-
esses. Mtb H37Rv or H37Ra were obtained from ATCC reposi-
tory and gfp-strains of Mtb were prepared as described before 
(Dhandayuthapani et al., 1995). They were cultured in 7H9 broth 
with (gfp expressing Mtb H37Rv or Mtb H37Ra strains) or without 
(Mtb H37Rv and Mtb H37Ra) 25 μg/mL kanamycin for 10 days 
and highly viable suspension aliquots frozen stored at −80°C.
Surface receptor analySIS
Cells were activated for 3 days using varying doses of PMA (1, 10, 
and 50 ng/mL) and RAVD (10, 100, and 1000 nM) and infected 
with Mtb H37Rv for 24 h. The infected cells were washed once 
with PBS and stained, on ice for 30 min, with FITC or PE con-
jugated anti-CD1d, CD14, CD44, CD80, CD86, CD184, CD195, 
DC-SIGN, and HLA-DR (all from BD Pharmingen, San Jose, CA, 
USA) antibodies. The cells were post-fixed with 2% paraformalde-
hyde before analysis using BD Facscan. PMA and RAVD activated 
and infected THPs were analyzed for mannose receptor expression 
by incubation with FITC-tagged mannosylated-BSA (FITC-mBSA; 
Sigma Aldrich, St Louis, MO, USA) for 30 min at 37°C after which 
the cells were washed and fixed for cytometric analysis (Takahara 
et al., 2004). In this assay, uptake of FITC-mBSA into THPs was 
performed incubated at both 4 and 37°C. At 4°C minimal uptake 
occurs compared to active uptake at 37°C.
InfectIon of tHps wItH Mtb and SHort-terM growtH curveS
Mtb suspensions were subjected to gentle sonication at 4 W, 
matched to McFarland standard #1 and spun at 500 rpm for 2 min. 
The supernatant contained single colony forming unit (CFU) 
of Mtb without clumps and were used for infection. Activated 
THP cells were infected with an MOI of 10 with Mtb for 24 h 
at 37°C and 5% CO
2
 with gentle mixing to ensure uniform 
infection. Cells were washed three times with sterile medium to 
remove non-phagocytosed bacteria, counted and dispensed to 
24-well plates (CFU counts, MNGC cultures) or 8-well chamber 
slides (Mtb uptake, immunostains) at 106 cells/mL medium in 
replicates. For growth curves between days 1 and 10, cells from 
24-well plates were aspirated, pelleted, and lysed in 0.05% SDS 
within the same well thus accounting for adherent as well as some 
floating macrophages. When macrophages were adherent both 
floater cells as well as adherent macrophages were pooled for 
preparing lysates, which were then plated at 10-fold dilutions 
on 7H11 agar (Remel, Lenexa, KS) for CFU counts. PMA-THPs 
generally die between days 7 and 10 due to an excess growth of 
Mtb while RAVD-THPs control growth of Mtb and cells remain 
viable. Viability of THPs during Mtb infection was determined 
by adding 10% by volume of alamar blue vital stain that turns 
pink when macrophages are fully viable. The dye conversion was 
quantitated using an Ascent fluorometer; it is also readable using 
an ELISA reader (Invitrogen, USA).
Lemaire et al., 1996; DeFife et al., 1997), lectins (Chambers, 1977; 
Takashima et al., 1993), monoclonal antibodies (Lazarus et al., 
1990; Orentas et al., 1992; Tabata et al., 1994), and conditioned 
media (Sone et al., 1981; Postlethwaite et al., 1982; Kreipe et al., 
1988; Abe et al., 1991). However, Mtb is a slow growing organ-
ism with a doubling time of about 18 h and the interaction of 
Mtb and macrophages is a chronic process in vivo lasting years. 
Paradoxically, the available models are limited by short life span 
of macrophages. The only long-term study of in vitro MNGC 
formation utilized freshly isolated PBMCs where the infection 
was carried through to 28 days.
We discovered that human THP-1 cells (henceforth cited as 
THPs) could be infected with live Mtb in vitro and treated with 
physiologically compatible vitamins to induce a differentiation 
process that resulted in the generation of MNGCs, that in turn, 
could be maintained for more than 60 days in culture. Due to the 
difficulty of obtaining alveolar macrophages, a human monocytoid 
cell line, THP-1, is commonly substituted for in vitro studies of 
macrophage responses to Mtb infection (Tsuchiya et al., 1980). 
THPs however need to be activated before they differentiate into 
a macrophage-like cell line (Theus et al., 2004). Phorbol myristate 
acetate (PMA) is the most common chemical activator for THPs 
(Tsuchiya et al., 1982), inducing adherence, upregulation of phago-
cytic receptors, and an overall macrophage-like state. However, 
PMA is toxic for humans in vivo, and is not a substance endog-
enously produced in the host. Unlike PMA, all-trans retinoic acid 
(RA; Kim et al., 2007) and vitamin D
3
 (VD; McCarthy et al., 1983) 
are THP activating agents that are basic components of a healthy 
diet and have been shown to be linked to immune responses against 
Mtb infection (Crowle et al., 1987; Crowle and Ross, 1989, 1990; 
Liu et al., 2007). We therefore examined the effects of PMA and 
retinoic acid and vitamin D
3
 (RAVD) on the phenotype and func-
tion of THP cells to develop an in vitro model that is closer to 
human alveolar macrophages. During these studies, we observed 
differing effects of PMA and RAVD activation of THP cells. PMA 
activated THPs (PMA-THPs) allowed enhanced growth of Mtb 
as observed previously. However, RAVD activated THPs (RAVD-
THPs) inhibited Mtb and, with the addition of physiologically 
relevant, increasing doses of RA and VD, sustained bacteriostasis 
occurred. Furthermore, only in RAVD-THPs, Mtb induced the 
generation and gradual evolution of various morphotypes of mac-
rophages to represent epithelioid cells, binucleate and MNGCs, 
culminating in syncytia. Thus, for the first time, it appears pos-
sible to study a chronic interaction between a slowly replicating 
bacterium that also has the unique ability to remain in a persistent 
state in macrophages.
MaterIalS and MetHodS
actIvatIon of tHps and MycobacterIa
Human THP-1 monocytoid cell line (TIB#3456, ATCC, MD, USA) 
was maintained at 37°C and 5% CO
2
 in HEPES buffered RPMI-
1640 (Sigma Aldrich, St Louis, MO, USA) medium with 10% heat 
inactivated FBS, 50 μg/mL gentamicin and 100 U/mL penicillin 
(pH 7.2). THPs were genotyped by ATCC to exclude contamina-
tion with other cell lines. Cells were passed so that cell counts did 
not exceed 106/mL. When needed, cells were expanded into 75 cm2 
flasks and were activated with RA (1 μM) and VD (1 μM) or PMA 
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buffer containing 1% saponin, 0.1% glycine, and 2% heat-inacti-
vated autologous human serum in PBS. The slides were washed 
and stained overnight at 4°C with 1/250 dilution of antibodies 
against p47/67phox, CD63, LAMP-1, Cat-D, and Cathepsin-G (Cat-
G). Antibody dilutions were arrived at using preliminary dose-
titrations. The slides were washed three times with staining buffer 
and then a 1:2500 dilution of the appropriate secondary Texas-Red 
conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 
was added and incubated at room temperature for 1 h. After fur-
ther washing, the slides were mounted in Fluorsave (Calbiochem, 
Gibbstown, NJ, USA) with or without DAPI stain and examined 
on a Nikon fluorescence microscope equipped with a deconvolu-
tion software followed by analysis in a laser confocal microscope. 
Negative controls consisted of naïve THPs (no activation) and 
uninfected activated THPs. In addition, isotype controls used were 
Mtb gfp H37Rv infected cells stained with normal goat or mouse 
IgG followed by a secondary antibody conjugated with Texas-Red. 
All uninfected and inactivated THPs presented a uniform low back-
ground fluorescence using this procedure. Phagosomes staining 
for distinct antibodies were scored for colocalization as described 
before in our previous studies using mouse macrophages (Daniel 
et al., 2006). For colocalization experiments, bacteria of over 100 
macrophages in each chamber of triplicate well slides were counted 
and averaged for three separate experiments. The colocalization 
percentage was plotted and Student’s t test was used to determine 
significance between the groups.
detectIon of reactIve oxygen SpecIeS and nItrIc oxIde
Activated THPs were treated with 2,7-dichlorodihydrofluorescein 
diacetate (H
2
DCFDA, Invitrogen, Carlsbad, CA, USA) as per the 
manufacturer’s instructions to measure internal reactive oxygen 
species (ROS) production in pre-and post Mtb infected macro-
phages. Basal levels of ROS in activated THPs were analyzed for a 
3-day period by flow cytometry. Mtb infected cells were incubated 
for 5 days and tested for intracellular fluorescence as above using 
fluorometry (Ascent Fluoroscan) instead of flow cytometry because 
of contamination issues and infectious risk with virulent Mtb. The 
specificity of ROS mediated conversion of dichlorofluorescein 
(DCF) was confirmed by using the ROS inhibitor, 10 mM diphe-
nyleneiodonium (DPI; Sigma Aldrich, St Louis, MO, USA). The 
contribution of inducible nitric oxide synthase (iNOS) to the kill-
ing of internalized Mtb was determined by the addition of 10 mM 
N(G)-monomethyl-l-arginine [l-NMMA; Alexis Biochemicals, 
San Diego, CA; an inhibitor of nitric oxide (NO) response] to the 
cultures and the supernatants were titrated using diaminonaph-
thalene (DAN) fluorescent dye and Ascent Fluoroscan instrument.
sirna KnocK-down of beclIn-1 to deterMIne InductIon of 
autopHagy
THP-1 cells were seeded 2 × 106 cells per well onto a 6-well plate 
and rested for 24 h in media without antibiotics. They were then 
activated with RAVD as above and 3 days later, the knock-down of 
beclin-1 was performed as per manufacturer’s instructions (Lonza 
AG, Walkersville, MD, USA) where the beclin-1 siRNA (Sigma 
Aldrich, St Louis, MO, USA) was nucleofected into the cells and 
allowed to rest for 24 h. Infection with Mtb was then performed for 
4 h, washed cells were re-incubated and lysates of macrophages were 
growtH and MaIntenance In SlIde cHaMberS
Cells plated onto 8-well chamber slides (Permanox plastic chamber 
slides, Nalge Nunc International, Rochester, NY, USA), became adher-
ent after Mtb infection and were fixed either with absolute alcohol for 
Ziehl–Neelsen stain and scored by microscopy for Mtb uptake into the 
macrophages or with 2.7% paraformaldehyde for immunostaining 
with antibodies. THPs in slide chambers were kept alive for several 
weeks or months with medium replenishment as described below.
long-terM cultureS of tHps and InductIon of MultInucleated 
gIant cellS
THPs infected with Mtb as above for short-term infection were con-
tinued into long-term cultures of MNGCs as follows. Only RAVD-
THPs were viable beyond 10 days of Mtb infection. On day 3 post 
infection, when RAVD-THPs begin to adhere to 24-well plates, cells 
were aspirated and fresh culture media containing RAVD (1 μM) 
was added to the culture plates. On day 10, when the cells had dif-
ferentiated and most adhered to the plastic surface, fresh media 
with RAVD supplement was added along with freshly activated but 
uninfected RAVD-THP cells to a final concentration not exceed-
ing 106 cells/mL. Thus, the only time Mtb was added to long-term 
cultures of THPs was during an initial infection. Thereafter, fresh 
media supplemented with RAVD was added every 3 days and freshly 
activated cells every 7 days. Pre-formed giant cells on monolay-
ers fused with freshly added THP cells yielding increasingly larger 
MNGC. Control cultures of THP-1 cells activated with RAVD and 
without Mtb infection did not survive beyond 10 days. (a) Growth 
curve of Mtb: During long-term infection lasting 10–60 days, Mtb 
infected THPs were adherent but some floaters were present. Thus, 
during this time interval cells were aspirated, pelleted, and lysed 
along with adherent cells on  monolayers to determine CFU counts. 
(b) Cell fusion to expand MNGCs: To demonstrate cell fusion, pre-
formed MNGCs adherent to tissue culture wells were added with 
carboxyfluorescein diacetate (CFSE) stained, RAVD-activated 
THPs. Cell fusion was visible between MNGCs fusing with CFSE 
stained single THPs. (c) Cytokine effects: RAVD and cytokines were 
compared for their ability to induce MNGCs by infecting THPs 
with Mtb and addition of either RAVD or recombinant human 
IL-4 and GM-CSF separately or in combination (R&D Systems; 
20 ng/ml/106 macrophages each). THPs were re-incubated with 
fresh IL-4 or GM-CSF, replenished daily. To determine synergistic 
effects, RAVD activated THPs were also added with the cytokines. 
(d) Viability analysis: Alamar blue was used as vital stain to deter-
mine viability of MNGCs. (e) Cytokines and chemokine secretion 
from MNGCs: Cytokines and chemokines secreted from MNGCs 
were quantitated using sandwich ELISA with paired antibodies 
(R&D Sciences, USA). Long-term cultures for MNGCs were per-
formed over 20 times with reproducible results within a 2-year time 
frame. (d) Phagosome analysis for proteases: Mtb phagosomes were 
purified from RAVD-THPs on day 12 using sucrose gradients and 
analyzed for Cathepsin-D (Cat-D) using western blot (Singh et al., 
2006; Katti et al., 2008; Rao et al., 2009).
IMMunofluoreScent labelIng
Activated THPs infected with Mtb gfp H37Rv were grown in 
8-well chamber slides were washed once with PBS, fixed in 2.7% 
paraformaldehyde and permeabilized for 30 min with a staining 
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CD1d, CD80, CD86). Chemokine receptors like CD195 and 
CD184 enable homing of macrophages to infected sites while 
other receptors like CD14 bind mycobacterial cell wall compo-
nents altering cytokine signaling. In our studies, RAVD and PMA 
had differential effects on receptor expression of THPs analyzed 
using flow cytometry. Receptors were generally up regulated in 
THPs activated with RAVD compared to PMA and in general 
there was a dose–response to RAVD. In an experiment repeated 
three times with similar results, THPs were tested naïve or treated 
with various concentrations of PMA or RAVD, infected with Mtb, 
and then stained for CD11c after 24 h. PMA and RAVD-treated 
THPs enhanced the expression of antigen presenting molecules 
HLA-DR, CD1d, CD80, and CD86 (Figures 1A–C). CD184 and 
CD195 were also increased in RAVD vs. PMA activated THPs 
along with the TLR-4 co-receptor, CD14. Such receptors may 
make THPs more responsive to chemokines enabling homing, 
infiltration, and bacterial detection. CD44 has been implicated as 
a receptor for Mtb but showed no difference between RAVD and 
PMA activated cells (Leemans et al., 2003). However, DC-SIGN 
was increased in RAVD-THPs, which is important for capture 
of Mtb and antigen presentation to T cells (Tailleux et al., 2003). 
Besides DC-SIGN, RAVD-THPs also showed an enhanced expres-
sion of macrophage mannose receptor (MMR). Since antibod-
ies binding to MMR are internalized, we used an active uptake 
of mBSA tagged with FITC (FITC-mBSA; Sigma Chemical Co., 
USA) at 37°C as a measure of MMR expression (Figure 1D; 
Takahara et al., 2004). When uptake of FITC-mBSA was measured 
at 4°C to rule out adsorption, there was reduced labeling. Uptake 
of FITC-mBSA was also analyzed among Mtb infected RAVD 
or PMA THPs and the MMR expression remained stable only 
in RAVD-THPs (not shown). MMR is a receptor for mannose 
capped moieties like lipoarabinomannan of Mtb (Kang et al., 
2005). Thus, data on DC-SIGN and MMR together indicate that 
RAVD-THPs yield a more mature phenotype of macrophages 
that could internalize Mtb more efficiently than PMA-THPs. 
Using separate studies, we confirmed that RA and VD each 
had activation effects on THPs, but the maximal expression of 
receptors was obtained only with their combination (Figure A1 
in Appendix).
pMa and ravd Have dIfferentIal effectS on tHe uptaKe and 
SurvIval of MycobacteriuM tuberculosis In tHps
Receptor expression in RAVD-THPs suggested that the optimal 
doses of RAVD and PMA were respectively 1 μM and 10 ng/mL 
(16 nM). The optimal activation time was 72 h. All further stud-
ies utilized this optimized dose and activation. Activated THPs 
were then infected with Mtb H37Rv (MOI of 10) and evaluated 
for uptake and control of Mtb infection. Microscopic analysis of 
Ziehl–Neelsen stained Mtb (acid fast bacilli; AFB) in fixed PMA 
and RAVD treated THPs demonstrated a differential uptake of 
Mtb (Figure 2A). RAVD-THPs were better able to engulf Mtb, 
where over 75% of the macrophage population had internalized 
at least one AFB, while only 60% of the PMA-THPs demonstrated 
internalized AFB. This correlated with the increased expression of 
mycobacterial up-take receptors (Figure 1). Paradoxically, sub-
sequent to uptake, RAVD-THPs controlled the infection with 
plated for CFU counts of Mtb. Just before infection, western blot 
analysis with an antibody to beclin-1 (Santa Cruz Biotechnology, 
USA) was conducted to determine knock-down. The fluid phase 
autophagosome marker monodansylcadaverine (MDC) was used 
to label Mtb phagosomes of beclin-1 knockdown and control THPs 
as described before (Jagannath et al., 2009).
electron MIcroScopy
Infected RAVD-THP cells were prepared for examination by trans-
mission electron microscopy. After the indicated incubation periods, 
the glutaraldehyde-fixed (2% in PBS, pH 7.6) cells were washed in 
Millonig’s buffer, post-fixed in 50/50 osmium tetroxide/Millonig’s, 
dehydrated through graded ethanol solutions and embedded in 
50/50 LX-112 resin/propylene oxide. Sections of 500 nm were cut 
from each block using a glass knife on a Leica Ultracut R microtome 
and stained with 0.5% Toluidine Blue. The blocks were trimmed 
and thin sections (80 and 100 nm) are cut using a DiATOME dia-
mond knife, one each of the two thicknesses are floated on either 
100 or 150 mesh copper grids (Electron Microscopy Sciences) and 
heat fixed in a 70° oven for at least 1 h. The grids were stained for 
15 min using 2% uranyl acetate, rinsed with double distilled water, 
stained 5 min in Reynolds lead citrate, rinsed and dried in a 70° 
oven. The specimen grids were imaged in a JEOL 1200 transmission 
electron microscope at 60 kV with digital images collected using a 
1 k × 1 k Gatan BioScan camera, Model 792.
analySIS of perSIStIng and non-replIcatIng Mtb In tHps
RAVD-THPs were activated and infected with Mtb gfp H37Rv 
as above and maintained as MNGCs in 8-well slide chambers or 
24-well TC plates up to 30 days or more. At time intervals (a) THPs 
of the 8-well slide chambers in triplicate were lysed with 200 μL per 
chamber of 0.01% SDS and the entire lysate was plated on 7H11 
agar plates for CFUs expressed per 106 macrophages, (b) replicate 
chambers of macrophages were washed at the same time, fixed 
and examined for Mtb gfp H37Rv through microscopic evalua-
tion, and expressed as number of Mtb per 100 macrophages per 
chamber in triplicate, and (c) THPs in parallel cultures of 24-well 
plates were lysed with RNAzol and mRNA obtained was analyzed 
using real-time PCR as described using the following primers 
for antigen 85B (Hu et al., 2000; Pai et al., 2000). The primers 
were: forward primer 5′-TCAGGGGATGGGGCCTAGCC-3′; 
reverse primer 5′-GCTTGGGGATCTGCTGCGTA-3′; RT primer 
5′-GCCGGCGCCTAACGAACTCTGC-3′; Taqman Probe: 85B-
TP 5′-FAM-TCGAGTGACCCGGCATGGGAGCGT-BHQ-1-3′. 
Fold-expression of mRNA from macrophage lysates was compared 
to mRNA messages from a 7-day viable culture of Mtb that was 
adjusted to contain 106 CFU/mL diluted from a suspension matched 
to McFarland #1 turbidity standard (108 CFU/mL).
reSultS
pHorbol MyrIStyl acetate and a coMbInatIon of retInoIc acId 
and vItaMIn d3 Induce dIfferent Surface receptor expreSSIon 
In tHps
Macrophages express several types of receptors with different 
functional consequences. Some mediate uptake of Mtb (CD44, 
DC-SIGN), while others help cross talk with T cells (HLA-DR, 
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infection. RA and VD each had modest inhibitory effects against 
intracellular Mtb but exerted stronger effects when combined 
(Figure A2 in Appendix).
Mtb better than PMA-THPs (Figure 2B). Mtb grew 10-fold over 
7 days within PMA-THP macrophages while RAVD treatment 
decreased Mtb colony counts (CFUs) by a log
10
 over 7 days of 
FIGure 1 | Phorbol myristyl acetate (PMA) and a combination of retinoic 
acid (rA) and vitamin D3 (VD) induce a differential expression of surface 
receptors on human THP-1 monocytoid cells. THPs were activated with 
varying doses (as indicated; C) of PMA or a mix of RA and VD for 72 h and 
were stained for surface receptors using either fluorescent antibodies (A–C) 
or fluorescent tagged ligands (D,e) and analyzed using Cellquest software. 
MFIs from three experiments were calculated to show significance as 
indicated (*MFI significantly increased in three experiments; t test). (A) THPs 
were activated and stained for receptors involved in uptake or binding to 
mycobacteria [DC-SIGN, CD14, and CD44] (B) chemokine receptors, CD184 
and CD195; and (C) CD80, CD86, CD1d, and HLA-DR receptors involved in 
antigen presentation. (D) THPs were activated and stained with mannosylated-
BSA-FITC (mBSA-FITC) or BSA-FITC at 37°C for active uptake and at 4°C for 
absorption control using flow cytometry as above. RAVD enhanced the 
expression of macrophage mannose receptor compared to PMA 
activated THPs.
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using the ROS inhibitor, DPI (not shown). Intracellular ROS was 
also quantitated following activation and Mtb infection using a 
fluorometer. RAVD-THPs with internalized Mtb showed increas-
ing ROS levels over 5 days while PMA-THPs showed a spike that 
declined by day 5 (Figure 3D). Together, these studies indicate that 
both before and after infection, RAVD-THPs had stronger ROS 
responses than PMA-THPs.
Finally, ROS specific effects were correlated to bactericidal kill-
ing. THPs were activated in the presence or absence of 10 mM each 
of DPI chloride, an inhibitor of ROS response or l-NMMA, an 
inhibitor of iNOS that generates NO. After inhibition, cell lysates of 
infected RAVD-THPs were plated for viable colony counts (CFU) 
at the end of 24 and 72 h infection. At both time points, inhibition 
of ROS response with DPI increased the viability of intracellular 
Mtb compared to inhibition of NO response (Figure 3E). Figure 3F 
shows that the supernatants of cultures contained detectable ROS 
and somewhat lesser levels of NO through 3 days of incubation. 
Differences in NO levels before and after inhibition were not as 
significant as those for ROS. However, inhibition of iNOS also 
allowed a greater number of Mtb to survive at 72 h of culture. We 
speculate that RAVD may promote intracellular changes associated 
with NO pathway that still remain to be unraveled.
ravd Induced autopHagy In tHpS leadS to InHIbItIon of Mtb 
growtH
A recent study demonstrated that VD can induce autophago-
some formation to kill internalized Mtb (Yuk et al., 2009). Since 
autophagy could be another antimicrobial pathway that can con-
trol Mtb infection, we investigated the ability of RAVD to induce 
autophagy. RAVD-THPs were treated or untreated with siRNA vs. 
beclin-1, to abolish autophagy and then were infected with Mtb. 
RAVD induced killing of Mtb was inhibited by siRNA vs. beclin-1 
(Figure 4A). Mtb phagosomes also colocalized with the autophago-
some marker MDC in RAVD-THPs while MDC uptake was absent 
in siRNA knockdown THPs (Figure 4B) and the THPs needed to 
be stained with a nuclear DAPI stain to visualize macrophages. 
These data suggested that the bactericidal activity of RAVD was 
also attributable in part to the induction of autophagy.
actIvatIon of tHp-1 MacropHageS wItH ravd leadS 
MacropHageS to dIfferentIate Into gIant cellS
A striking change observed during in vivo TB is the morphologi-
cal transformation of macrophages into various morphotypes in 
guinea pigs, rats, rabbits, and humans (Parks and Weiser, 1975; 
Cain and Kraus, 1982; Kraus, 1982). Interestingly, PMA-THPs 
with phagocytosed Mtb progressively led to a loss of viability of 
macrophages after 7 days due to uncontrolled growth of bacteria 
(Figure 5A). On the other hand, RAVD-THPs were able to con-
trol Mtb infection and prevent loss of macrophages. Furthermore, 
RAVD induced cell fusion to form giant cells. Figure 5B illustrates 
the growth curve of intracellular Mtb recovered from adherent 
macrophages between days 1 and 10 and then from adherent 
MNGCs between days 10 and 35. Notably, not all THPs fused 
to form giant cells and some remained non-fused but markedly 
enlarged. Such cells contained single nuclei and a single intracel-
lular Mtb. Figure 5C illustrates the nuclear morphology of DAPI 
stained MNGCs that contain Mtb gfp H37Rv grown over 35 days of 
ravd enHance reactIve oxygen SpecIeS and nItrIc oxIde 
reSponSeS In tHpS tHat lead to InHIbItIon of Intracellular 
Mtb
To determine the basis for the anti-TB effects of RAVD, ROS and 
NO production was evaluated among activated and Mtb infected 
THPs. When Mtb is internalized by macrophages, it is sequestered 
within a phagosome that triggers the acquisition of the multimeric 
components of the NADPH oxidase [phagocyte oxidase (phox)]. 
In our earlier study, we demonstrated that NADPH oxidase colo-
calizes with Mtb phagosomes in macrophages and the colocaliza-
tion, one evidence of targeting of the enzyme to Mtb phagosomes, 
is detectable using antibody stain against p47/67phox components 
(Daniel et al., 2006). Accordingly, RAVD or PMA treated THPs 
were infected with Mtb gfp H37Rv, immunostained and scored 
microscopically for colocalization (Daniel et al., 2006). PMA-THPs 
showed a reduced colocalization of the NADPH oxidase proteins 
with Mtb phagosomes while RAVD-THPs showed an enhanced 
colocalization (Figures 3A,B).
These studies correlated with the intracellular levels of ROS in 
PMA and RAVD activated THPs, determined using a ROS specific 
probe, 2′,7′-dichlorodihydrofluorescein diacetate (H
2
DCFDA). 
Non-fluorescent H
2
DCFDA is cleaved by intracellular esterases 
to yield the DCF, which is then oxidized by ROS to yield a fluo-
rescent hydrophobic product trapped within the cell. Figure 3C 
shows the flow cytometric analysis of fluorescent ROS positive cells 
after activation and before infection as analyzed by flow cytom-
etry. PMA-THPs showed an increased shift due to ROS induced 
fluorescence on day 1 that returned to background levels by day 3. 
On the other hand, RAVD-THPs showed a shift on day 1 that was 
sustained until day 3 when the cells were infected with Mtb. The 
specificity of ROS mediated conversion of DCF was confirmed by 
FIGure 2 | Phorbol myristate acetate and rAVD have differential effects 
on the survival of Mycobacterium tuberculosis (Mtb) within THP-1 
macrophages. (A) THPs were activated with either 10 ng/mL of PMA or 1 μM 
each of RA and VD for 72 h and phagocytosed with Mtb for 4 and 24 h. 
Bacteria internalized were visually scored by microscopy using acid fast stain. 
Mtb uptake by THPs is significantly increased after RAVD treatment 
(*p < 0.009, t test; three experiments). (B) THPs activated and infected as 
above were incubated for 10 days and were lysed at intervals and plated for 
colony (CFU) counts. RAVD treatment inhibited bacterial replication while Mtb 
showed an increase in colony counts in PMA treated macrophages 
(*p < 0.009, t test; three experiments).
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FIGure 3 | rAVD induces an enhanced reactive oxygen species (rOS) 
response in THP-1 macrophages that leads to inhibition of intracellular 
Mtb. (A) THPs were activated with either PMA or RAVD and phagocytosed 
with gfp-expressing strain of Mtb (gfp H37Rv) for 4 h followed by fixation and 
staining with antibodies against p47/p67phox components of the phagocyte 
(NADPH) oxidase. Percent phagosomes colocalizing with gfp H37Rv (arrows) 
were scored in three experiments and average colocalization shown (B). 
Arrowhead in (A) shows a non-colocalizing gfp H37Rv (bars = 5 μM). (C) THPs 
activated with PMA or RAVD were labeled with 2′,7′-dichlorodihydrofluorescein 
diacetate (H2DCFDA), a probe for intracellular ROS, and quantitated using flow 
cytometry on day 1 (black), day 2 (green), and day 3 (blue). RAVD-THPs 
maintained ROS production over 3 days, whereas ROS response declined in 
PMA-THPs after day 2 (one of three similar experiments shown). Red fill shows 
basal levels of ROS production in naïve (inactivated) THPs. (D) THPs activated 
with RAVD were infected and measured for intracellular ROS using an 
Ascent-Fluoroscan that quantitated ROS in average fluorescence units (AFU). 
Data show that ROS increased in RAVD-THPs over 3 days of activation but 
decreased by day 3 in PMA-THPs. (e) THPs were activated with RAVD, infected 
with Mtb and then incubated in the presence or absence of 10 mM of 
diphenyleneiodonium chloride (DPI) an inhibitor of ROS response or 
N-monomethyl-l-arginine (l-NMMA) an inhibitor of nitric oxide response. 
Macrophage lysates were then plated for CFU counts at the end of 24 and 72 h 
of infection. Inhibition of ROS response with DPI increased the viability of 
intracellular Mtb compared to inhibition of NO response (p values shown above 
bars for groups compared, t test; three experiments). (F) Supernatants of 
macrophage cultures of (e) were tested added with H2DCFDA or 
diaminonaphthalene (DAN) and read for fluorescence in an Ascent fluoroscan to 
measure respectively, ROS or NO induced average fluorescence units (AFU).
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THPs while those treated with cytokines died within 20 days due 
to extensive multiplication of intracellular Mtb (not shown). In the 
continuation of RAVD treated cultures shown in Figure 6A1, that 
were maintained up to 60 days without the loss of viability, freshly 
added uninfected THPs (arrowhead, Figures 6A2–4) fused with 
preformed adherent MNGC (arrows, Figures 6A3,4) in culture 
to yield long living MNGCs surviving up to 60 days (Figure 6A5). 
While cytokines were not required for MNGC formation using 
RAVD-THPs followed by Mtb infection, interestingly, they secreted 
both cytokines and chemokines. After an initial burst of cytokines 
(TNF-α, IL-6, and IL-10), RAVD-THPs showed a decline in the 
level of cytokines (TNFα, IL-6, and IL-10) after day 21 but switched 
to higher levels of chemokine (MCP1, MIP1α, and KC) secretion 
(Figure 6B). These data support a novel protocol that has been 
optimized to enhance in vitro longevity of MNGCs.
long lIvIng Mngcs contaIn perSIStIng M. tuberculosis In 
proteaSe rIcH coMpartMentS
To the best of our knowledge, there are no in vitro cell culture 
models to study long-term persistence of Mtb. Since RAVD-
induced MNGCs remained viable even after several weeks and 
contained Mtb gfp H37Rv, we sought to determine mechanisms 
that led to their persistence. We speculated that Mtb in RAVD was 
persistent since replicating bacteria were either killed in acidic 
compartments of THPs or after the initial bactericidal action 
from RAVD, Mtb did not multiply subsequently and remained 
dormant. In addition to oxidant mediated killing of Mtb, mac-
rophages use phagosome–lysosome (P–L) fusion to kill Mtb via 
lysosomal hydrolases. Generally, Mtb avoids P–L fusion in human 
macrophages; however, VD has been reported to enhance P–L 
fusion (Hmama et al., 2004). An evidence of P–L fusion is the 
in vitro culture with representative phase contrast images. Finally, 
when MNGCs fuse with additional macrophages, the zone of fusion 
is delineated by characteristic inter-digitations observable through 
electron microscopy (EM; Bainton and Golde, 1978). Figure 5D 
illustrates an EM image of MNGC fusing with individual THP. In 
addition, it has been reported that “a disintegrin and metallopro-
teinase” (ADAM) family of proteins mediate mycobacteria induced 
cell fusion (Puissegur et al., 2007). We stained RAVD-THPs for 
several ADAMs and found that RAVD induced only a transient 
staining for ADAM-9 between THPs undergoing cell fusion early 
during infection (Figure A3 in Appendix).
long-terM actIvatIon of tHp-1 MacropHageS wItH ravd leadS 
to long lIvIng Mngcs tHat contaIn perSIStent M. tuberculosis
Mycobacterium tuberculosis infected THPs were constantly moni-
tored using alamar blue fluorescent dye that was added to cultures 
and rapidly converted by viable cells into red-fluorescent products 
in turn measured using fluorometry (100 AFU emission equals 
100% viability for 1 × 105 THPs).
effect of cell fuSIon InducIng cytoKIneS Il-4 and gM-cSf vS. 
ravd on Mngc forMatIon froM Mtb Infected tHpS
Some cytokines like IL-4 and GM-CSF have been known to induce 
fusion of human peripheral blood derived monocytes or rat mac-
rophages leading to the formation of short lived MNGCs (Sorokin 
et al., 1992; Purton et al., 1996). To determine their effects on lon-
gevity of MNGCs, THPs were activated with IL-4, GM-CSF, their 
combination or a combination with RAVD followed by infection 
with Mtb. MNGCs and viability were monitored using microscopy 
and alamar blue assay in culture for 40 days. Figure 6A1 illustrates 
that only THPs treated with RAVD induced prolonged survival of 
FIGure 4 | Induction of autophagy in rAVD-THPs leads to enhanced 
survival of intracellular Mtb. RAVD activated THPs treated or untreated with 
siRNA vs. beclin-1 to knock-down autophagy, were infected with Mtb gfp 
H37Rv (MOI of 10). Lysates were then plated for CFU counts at the end of 
24 h infection. (A) Inhibition of autophagy with siRNA Beclin-1 increased the 
viability of intracellular Mtb compared to siRNA control (p values shown above 
bars for groups compared, t test; three experiments). 
(B) Monodansylcadaverine (MDC) was used to label autophagosomes in 
similar type of THPs. Mtb gfp H37Rv colocalizes with MDC in RAVD treated 
macrophages. MDC uptake was poor in siRNA vs. beclin-1 macrophages 
so that the nuclei were labeled with DAPI to visualize macrophages and 
gfp H37Rv.
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involved in maintaining lysosome acidity and protecting the lyso-
somal membranes from autodigestion. RAVD-THP phagosomes 
containing Mtb showed extensive colocalization with CD63 and 
LAMP1 (Figures 7D,E). Together, these studies argue that RAVD 
markedly enhances the localization of Mtb into protease rich deg-
radative lysosomal compartments within THPs that could account 
for persistence without replication.
perSIStent M. tuberculosis In Mngc IS MetabolIcally actIve
Irrespective of antibody stains used or the time of examination 
for THPs, some gfp Mtb remained completely unstained by either 
protease or lysosomal markers within THPs. Figure 8A illustrates 
such Mtb bacilli, which are apparently viable and gfp-fluorescent 
even after 20 days in culture do not stain with LAMP1, a late P–L 
marker. Preliminary EM studies showed similar mycobacteria that 
apparently remained in the cytosol of macrophages without a dis-
tinct phagosomal membrane (not shown).
We speculated that such Mtb were cytosolic and thus do not 
stain with membrane markers such as LAMP1. We also proposed 
that persistence was likely related to the virulence of Mtb. To 
accumulation of active proteases that can kill Mtb. Thus, Mtb 
phagosomes were fractionated from RAVD-THPs on day 12 using 
sucrose gradients (Singh et al., 2006).
Blots were initially analyzed for Cat-D, a major enzyme pro-
teolytic for Mtb in acidic environments (Singh et al., 2006) whose 
active forms are demonstrable only by western blot. Cat-D breaks 
down from a 52-kDa immature inactive form to an enzymatically 
active 32 kDa form in an acidic pH. Figure 7A illustrates that Mtb 
phagosomes contained the inactive Cat-D form 24 h after infection 
while by the end of 72 h, active fragments of Cat-D appeared within 
the phagosomes. Immunofluorescence was then used to confirm 
that both Cat-D and another bactericidal protease, Cat-G (Rivera-
Marrero et al., 2004) localized to Mtb gfp H37Rv phagosomes 
(Figures 7B,C). Thus, Mtb gfp H37Rv within RAVD-THPs localized 
to protease rich compartments after RAVD activation. Finally, the 
lysosomal localization of Mtb was confirmed by using antibodies to 
the lysosomal markers, LAMP1 and CD63 (Figures 7D,E). CD63, a 
definitive marker of lysosomes is present in abundance in activated 
macrophages and is speculated to play a role in phagocytic and P–L 
fusion events (Astarie-Dequeker et al., 1999). Likewise, LAMP1 is 
FIGure 5 | Long-term activation with rAVD allows phenotypic changes 
in M. tuberculosis infected THP-1 macrophages that lead to multi-
nucleate giant cell (MNGC) formation. (A) THPs activated with either PMA 
or RAVD were infected at an MOI of 1 with gfp H37Rv and incubated for 
10 days. By day 7 PMA-THPs show robust intracellular growth of Mtb and by 
day 10, most of the PMA cells die of bacterial growth (bar = 5 μM). (B) Left: 
Growth curves of PMA and RAVD-THPs with Mtb show the kinetics of 
growth and phenotypic change. Right: Alamar blue was added to replicate 
cultures and supernatants measured for emission at 590 nm in a fluorometer 
and expressed as AFUs (100 AFU = 100% viability; 106 THPs well; dye 
conversion in 4 h). (C) Replenishment of RAVD, fresh medium and uninfected 
THPs every 7 days to the cell culture, prolonged the survival of adherent Mtb 
infected RAVD-THPs, progressively showing morphology typical of MNGCs. 
Progressive formation of giant cells is shown by DAPI stained nuclei of THPs 
with intact gfp H37Rv bacilli and representative phase contrast images 
(bars = 5 μM). (D) Electron microscopy (left panel) shows that macrophages 
fuse with adjacent THPs through a zone represented by inter-digitating- 
septae. A single intact Mtb phagosome (white arrow) with tight membranes 
and a phagosome in a vacuole (black arrow) are shown in a RAVD-THP in the 
right panel.
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(Figure 8B). Progressively, Mtb gfp H37Ra were eliminated from 
RAVD-THPs while only Mtb rfp H37Rv was detectable until day 
30. This suggested that persistence within macrophages is a feature 
of only virulent H37Rv strain of Mtb.
 investigate this aspect, RAVD-THPs were infected concurrently 
with Mtb gfp H37Ra and red-fluorescent expressing Mtb H37Rv 
(rfp H37Rv). THPs were then cultured for 30 days and fluorescent 
bacteria enumerated by counting 100 THPs per triplicate  chambers 
FIGure 6 | Activation with rAVD but not cell fusion-inducing cytokines 
leads to long lived MNGCs containing M. tuberculosis. (A1) Survival of Mtb 
infected THPs measured after treatment with either recombinant human IL-4 or 
GM-CSF or their combination with RAVD. Fluorescent conversion of the vital dye 
alamar blue was used to monitor viability of THPs (100% viability = 100 AFUs 
from 24-well cultures measured at 485/530 nm using Ascent fluoroscan). Only 
THPs treated with RAVD-THPs prolong survival measured up to 40 days in this 
experiment. Those treated with IL-4 or GM-CSF die because of excess growth of 
Mtb (not shown). (A2) RAVD cells of (A1) examined under phase contrast 
shows a MNGC (arrow) fusing with single THPs (arrowhead) on day 45. (A3,4) 
Preformed (day 45) adherent MNGCs (pale green; white arrows) that contain 
multiple gfp H37Rv fuse with freshly added uninfected, carboxyfluorescein- 
diacetate (CFSE) stained THPs (T; arrowheads) to form expanded MNGCs 
(bar = 5 μM). (A5) Phase contrast images of MNGCs on day 60 tend to show 
syncytium formation (bars = 5 μM). (B) Supernatants of RAVD MNGCs of (A1) 
collected on days of culture shown were measured for cytokine–chemokines 
using sandwich ELISA. RAVD activated and Mtb infected THPs show an initial 
burst of cytokines and later burst of chemokines.
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dIScuSSIon
Monocytes and monocytoid cell lines generally express reduced 
numbers of receptors and are less efficient in phagocytosing patho-
gens (Schwende et al., 1996). However, differentiated macrophages 
express abundant receptors, are more phagocytic, and have enhanced 
intracellular mechanisms of bactericidal activity mediated by phox, 
iNOS, increased targeting of proteolytic enzymes such as cathep-
sins and enhanced P–L fusion (Schwende et al., 1996). Monocyte 
to macrophage differentiation occurs after binding of pathogens 
to monocytes via their receptors in combination with the release 
of self-activating cytokines such as TNF-α, G-CSF, and GM-CSF. 
Differentiation can be induced in vitro by phorbol esters (Tsuchiya 
et al., 1982), VD (Kim et al., 2007), and RA (McCarthy et al., 1983). 
However, following infection in vivo macrophages transform into 
Langhans type of MNGCs that are surrounded by immune cells 
of granulomas and contain Mtb thought to be non-replicating 
or dormant. Classic histological studies show that such bacilli 
reactivate to cause active infection while MNGCs can revert into 
macrophage phenotype and spread infection in rabbits and guinea 
pigs (Hektoen, 1898). To the best of our knowledge, an in vitro 
Finally, attempts were made to determine whether persistent 
Mtb were metabolically active. For this purpose, gfp Mtb infected 
RAVD-THPs were maintained concurrently in 24-well plates as 
well as 8-well slide chambers over 30 days. First, gfp Mtb infected 
RAVD-THPs cultured in 8-well slide chambers were fixed at dif-
ferent time intervals and intracellular gfp Mtb were scored per 
100 macrophages and correlated to viable counts by plating whole 
cell lysates of replicate chamber THPs. Figure 8C illustrates that 
even when viable Mtb were not culturable on agar plates, gfp Mtb 
were microscopically observable within THPs of slide chambers. 
In the second experiment, Mtb infected RAVD-THPs were tested 
over time for the expression of mRNA for antigen-85B, which 
is a reliable marker for viability of replicating as well as non-
replicating, persistent Mtb (Hu et al., 2000; Pai et al., 2000). 
Figure 8D shows that even when viable Mtb were not recovered 
from THPs on day 30, mRNA for antigen 85B was expressed 
indicating that viable Mtb persisted within THPs. We therefore 
suggest that treatment of THPs with RAVD leads, over time, to a 
decline in the viability of Mtb and that some of bacteria appear 
to enter a persistent state.
FIGure 7 | Long-term activation with rAVD leads to increased protease 
activity and lysosomal localization of Mtb in THP1 macrophages. THPs 
were activated with RAVD infected with gfp H37Rv and processed as follows. 
(A) Phagosomes containing gfp H37Rv were purified from day 12 RAVD-THPs 
using sucrose gradients. Phagosome pellets and post-nuclear supernatants 
(PNS) were analyzed with Western blot using antibodies against Cathepsin-D 
(Cat-D). Blot shows the enrichment of Cat-D protease in the phagosomes 
compared to PNS and the accumulation of enzymatically mature 33 kDa 
fragment over time. Bottom lane shows loading control β-actin. (B–D) 
RAVD-THPs on day 12 were stained for Cat-D, Cat-G (B,C), and CD63 and 
LAMP1 (D,e) using specific antibodies and counterstained with Texas-Red 
labeled conjugates. (B–D) Show Mtb phagosomes of RAVD-THPs colocalizing 
with antibodies for proteases and lysosomal markers. Bar graphs of (C–e) show 
quantitation of colocalizing phagosomes. The average length of Mtb was 5 μM.
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in the synergistic presence of the two vitamins. Subsequently, RAVD 
exerted more effective bactericidal effects compared to RA or VD 
alone. These effects were due in part to the induction of NADPH 
oxidase although there was evidence that modest induction of iNOS 
also occurred. Significantly, RAVD induced macrophage mediated 
killing of most Mtb organisms but a few were left to survive within 
model of human macrophages that undergo phenotypic changes 
closely associated with a transition from replicating Mtb into per-
sistent Mtb has not been reported before. We suggest that an RAVD 
induced MNGC model is more similar to events that occur within 
humans during TB. We observed that RA and VD were separately 
able to activate THPs, although maximal differentiation occurred 
FIGure 8 | Persistence of M. tuberculosis in rAVD-THPs is a characteristic 
of virulent H37rv strain. RAVD-THPs were infected with Mtb strains, 
maintained in parallel over 30 days in 8-well slide chambers or 24-well plates and 
analyzed as follows: (A) RAVD-THPs immunostained at intervals showed gfp 
H37Rv counterstained for LAMP1 from day 7 through day 20 (broken arrow) but 
some bacilli remain unstained (solid arrow). (B) RAVD-THPs were concurrently 
infected with gfp H37Ra and rfp H37Rv and bacteria were scored in 100 THPs at 
each time point as indicated. Only rfp H37Rv survived in RAVD-THPs while gfp 
H37Ra was eliminated (bar graph). The average length of Mtb was 5 μM. (C) gfp 
H37Rv were enumerated per 100 THPs through microscopy in triplicate 
chambers of slide culture and replicate chamber THPs were lysed and plated for 
CFUs on 7H11 agar as a whole to recover CFUs. RAVD-THPs with 
microscopically visible, persisting Mtb showed no growth in agar plates by day 
30. Data from three separate experiments were averaged and shown. 
(D) A parallel culture of experiment shown in (C) was set up and RAVD-THPs 
were analyzed at time intervals for mRNA specific for Antigen 85B of Mtb using 
RT-PCR and for CFU counts in macrophage lysates on days indicated. On day 30, 
mRNA messages were detected even when Mtb were not recoverable on agar 
media from lysates of THPs suggesting non-replicating persistence of Mtb in 
RAVD-THPs.
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that their combination is likely more effective in inducing MNGC 
formation in THPs. In addition, we found that RAVD induced 
cell fusion through the induction of the matrix metalloproteinase 
(ADAM-9) that was detectable only as a transient staining between 
the cell junctions (Figure A3 in Appendix). Finally, RAVD induced 
MNGCs could be kept in vitro for observation for 60 days yielding 
the longest living giant cell phenotype in culture.
A more interesting observation was the persistence of Mtb in 
MNGCs in a non-replicating stage for as long as 60 days in vitro. 
First, microscopy showed more fluorescent-Mtb per MNGC than 
recoverable colony counts from lysates of MNGCs. Second, MNGCs 
positive for gfp Mtb but negative for CFU growth on plate media 
still expressed mRNA for Antigen-85B, which is a marker for viable 
as well as persistent Mtb (Hu et al., 2000). This was reminiscent of 
our previous observation that persistent, non-replicating Mtb in 
mice treated with antibiotics still expressed abundant mRNA for 
Antigen 85B (Pai et al., 2000). Third, only Mtb gfp H37Rv persisted 
in MNGCs after continuous treatment with RAVD, while under 
similar conditions, Mtb gfp H37Ra organisms were progressively 
eliminated. These studies together indicate that RAVD eliminate 
most replicating Mtb through inducing bactericidal functions but 
a few surviving Mtb are driven into a non-replicating persistence. 
Thus, we have successfully developed a novel macrophage model to 
study the long-term persistence of Mtb. To the best of our knowl-
edge an in vitro model to maintain MNGCs for prolonged periods 
(60 days) or Mtb in a persistent state has not been described. The 
availability of a cell culture model that reflects the natural niche for 
Mtb in vivo is important from several directions. It may be possible 
to study the dynamics of persistence over time and devise methods 
to eliminate persistent Mtb. Analysis of MNGCs may reveal mecha-
nisms that keep replicating Mtb contained and unable to spread 
disease. Preliminary studies were performed to neutralize both ROS 
and NO in MNGCs to determine whether persistent Mtb could be 
revived with unsuccessful results. Perhaps this could be due to the 
novel fact that Mtb compartments had RAVD induced active Cat-D 
and Cat-G which are known to be bactericidal. Thus, we propose 
that reactivation of Mtb within macrophages is dependent upon 
multiple, perhaps time-dependent, factors that need to be care-
fully dissected out. These include the blockade of multiple mecha-
nisms of bactericidal activity and cytokine mediated modulation 
of MNGCs in conjunction with stimulation of intracellular Mtb 
through growth stimulatory “quorum sensing factors.” The avail-
ability of persistent Mtb within a macrophage niche is an attractive 
model to address these issues.
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the macrophages that remarkably transformed into MNGCs. Such 
MNGCs produced copious cytokines and chemokines suggesting 
that they may be capable of recruiting and activating immune cells 
should they were in vivo. This is the first report of the induction 
of long living MNGCs with Mtb infection using activation with 
physiologically compatible macrophage modulators such as RA 
and VD. Addition of cytokines such as GM-CSF and IL-4 did not 
markedly alter the RAVD induced transformation of MNGCs. This 
suggested that RA and VD mediated biochemical processes separate 
from those induced by the cytokines.
The induction of MNGCs by RAVD correlated and clarified pre-
viously reported observations. VD was found to enhance DC-SIGN 
levels in THPs earlier and the well documented role of DC-SIGN in 
mycobacterial recognition was consistent with the increased efficacy 
of RAVD-THPs during phagocytosis. Likewise, increased expres-
sion of mannose receptor (MMR) in RAVD-THPs correlated with 
the finding that inhibition of MMR prevented MNGC formation 
(McNally et al., 1996). Clearly, RAVD transformed THPs and we 
suggest that, by inference, they regulate differentiation of human 
monocytes to a more efficient macrophage phenotype.
The bactericidal function of RAVD in THPs was partly due 
to the induction of ROS, since the ROS inhibitor DPI enhanced 
survival of Mtb. Although other pathways cannot be ruled out, this 
was similar to the previously reported induction of ROS by RA 
(N’Diaye et al., 1997). Recently a study showed that VD alone can 
induce autophagosome formation to kill internalized Mtb (Yuk 
et al., 2009). Knock-down of beclin-1, a key protein involved in 
targeting vesicles for autophagy, demonstrated that RAVD can also 
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FIGure A3 | A combination of retinoic acid (rA) and vitamin D3 (VD) 
induces expression of ADAM-9 integrin on THPs adjacent to each other 
(arrow) before cell fusion.
FIGure A2 | A combination of retinoic acid (rA) and vitamin D3 (VD) 
controls the growth of M.tuberculosis in THP1 macrophages better than 
rA or VD alone.
FIGure A1 | A combination of retinoic acid (rA) and vitamin D3 (VD) 
induces a better expression of DC-SIGN in THP1 macrophages than rA or 
VD alone.
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